New Seqirus Data Published in Vaccines Highlight Effectiveness and Economic Benefit of Cell-Based Quadrivalent Seasonal Influenza Vaccine (QIVc) in the 2018/19 U.S. Influenza Season
SUMMIT, N.J., March 25, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced the publication of new real-world...